Peptide Protocol
Peptide Protocol
App Store

DSIP: the complete guide

DSIP is a naturally occurring nonapeptide first isolated from the brains of sleeping rabbits. It is studied for effects on sleep architecture, stress resilience, and pain modulation.

Written by Peptide Protocol Editorial Medically reviewed per our review process Last reviewed
ClassNonapeptide neuromodulator
Half-lifeApproximately 7–15 minutes (very short plasma half-life)
Typical dose100–300 mcg per injection, typically at bedtime
CategorySleep / neuromodulator
Research useSleep quality research, stress modulation
FDA statusNot FDA approved. Research use only.

How DSIP works

DSIP's exact receptor target is not fully characterized, but it appears to modulate GABAergic and opioid pathways, influencing slow-wave sleep and HPA-axis stress response.

Typical DSIP dosage

Commonly reported research ranges: 100–300 mcg per injection, typically at bedtime.

Dose should always be individualized. Factors that influence it include bodyweight, research goal, tolerance, and specific compound batch. The information below is educational, not a prescription.

How to reconstitute DSIP

A widely used reconstitution for a 5 mg vial is 2 ml of bacteriostatic water. With a typical 100 mcg dose this works out to the unit count shown in the calculator below.

Open the DSIP reconstitution calculator →

Pre-filled with the common 5 mg + 2 ml ratio. Adjust for your own vial.

Half-life and administration frequency

Approximately 7–15 minutes (very short plasma half-life).

This half-life informs how often DSIP is typically dosed. Shorter half-lives usually mean more frequent dosing to maintain plasma levels; longer half-lives allow daily, weekly, or less-frequent administration depending on the compound.

Reported side effects

This list reflects effects reported in available literature or user logs. It is not exhaustive. Adverse reactions should be discussed with a qualified clinician.

Common DSIP stacks

Storage and handling

Lyophilized refrigerated. Reconstituted: refrigerated, use within 14–28 days.

FDA and regulatory status

Not FDA approved. Research use only.

DSIP clinical trials and evidence

For clinical-trial and primary-literature context, start with the sources below. We prioritize official drug labels, ClinicalTrials.gov records, and PubMed-indexed literature when available.

Track your DSIP protocol on iPhone

Peptide Protocol logs every dose, calculates reconstitution for you, and keeps your full protocol on one calm screen.

See the app →

Frequently asked questions

What is DSIP?

DSIP is a naturally occurring nonapeptide first isolated from the brains of sleeping rabbits. It is studied for effects on sleep architecture, stress resilience, and pain modulation.

How does DSIP work?

DSIP's exact receptor target is not fully characterized, but it appears to modulate GABAergic and opioid pathways, influencing slow-wave sleep and HPA-axis stress response.

What is a typical DSIP dose?

Commonly reported ranges are 100–300 mcg per injection, typically at bedtime. This is research information, not a recommendation — dosing should be individualized under clinical guidance.

What is the half-life of DSIP?

Approximately 7–15 minutes (very short plasma half-life). This influences how often it is administered.

How do you reconstitute DSIP?

A common approach is to add 2 ml of bacteriostatic water to a 5 mg vial. Use the reconstitution calculator for exact unit counts.

What are the side effects of DSIP?

Generally well-tolerated in short-term use; Mild headache; Grogginess on waking (uncommon); Long-term safety data sparse.

Is DSIP FDA approved?

Not FDA approved. Research use only.

Are there clinical trials for DSIP?

Registered or published clinical-trial sources for DSIP are listed in the references section below. Evidence depth varies widely by compound, so check the cited trial registries and primary literature before relying on any claim.

References

  1. Delta Sleep-Inducing Peptide (DSIP) literature (PubMed)National Library of Medicine. Primary research on DSIP and sleep architecture
  2. Schoenenberger & Monnier — DSIP identification and early characterizationPubMed. Foundational papers on DSIP discovery
  3. DSIP clinical trial recordsClinicalTrials.gov. Limited registered trials — clinical efficacy remains contested

Sources listed above were used to verify the claims on this page. See our editorial policy for how we source information.

Educational use only. Peptide Protocol is an informational tool. Nothing on this page constitutes medical advice. Many peptides are prescription-only or restricted in your jurisdiction. Always consult a licensed healthcare professional before injecting any compound.